DED Origin Story: Understanding the Role of Meibomian Gland Dysfunction (MGD)
Webcast
1 AMA PRA Category 1 Credit™ OVERVIEW
DED Origin Story: Understanding the Role of Meibomian Gland Dysfunction (MGD) is organized by Evolve Medical Education (EME) LLC.
Release Date: May 19, 2023
Expiry Date: May 19, 2024
Overview:
Discussing how meibomian gland dysfunction interacts with dry eye disease and the latest data on new and emerging treatments. This content was captured during a live symposium.
Learning Objectives:
Upon completion of this activity, the participant should be able to:
• Diagnose dry eye disease (DED) by subtype based on signs and symptoms
• Articulate how meibomian gland dysfunction (MGD) interacts with DED
• Summarize the latest data on treatments for MGD
• Compare the pipeline agents nearest to regulatory approval and explain their mechanisms of action
ACCREDITATION & CREDITS
Accreditation and Designation Statement
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMEC®s) should contact the UEMS at mutualrecognition@uems.eu.
TARGET AUDIENCE
PhysicianOptometristSPECIALITIES
Optometry
Quick Links